Union Bank of India has given a return of 109.08 percent over the last one year. The benchmark Nifty Bank index has given a return of 10.88 percent over the same duration. Read More Union Bank of India has given… Read More »Union Bank of India defies correction in PSU lenders, stock rallies 3%
Union Bank of India has given a return of 109.08 percent over the last one year. The benchmark Nifty Bank index has given a return of 10.88 percent over the same duration. Read More Union Bank of India has given… Read More »Union Bank of India defies correction in PSU lenders, stock rallies 3%
One pact is with Lloyd#39;s Register for development of a hydrogen fuel cell ferry, and the other with Caterpillar Inc for a potential collaboration in the production, sale and service of medium speed engines particularly for Indian Navy and Indian… Read More »Garden Reach surges 3% on pacts with Caterpillar and Lloyd#39;s Register
Because of several positive factors for Signature Global, there is a strong possibility of re-rating in the long run Read More Because of several positive factors for Signature Global, there is a strong possibility of re-rating in the long run… Read More »Signature Global IPO: Higher earnings growth in coming years to lend a hand to valuation
The slump in shares of RIL and HDFC Bank collectively contributed around 140 points to the Nifty 50#39;s near 175-point decline. Read More The slump in shares of RIL and HDFC Bank collectively contributed around 140 points to the Nifty… Read More »Mid-day Mood: Indices under pressure as caution prevails before FOMC outcome
The slump in shares of RIL and HDFC Bank collectively contributed around 140 points to the Nifty 50#39;s near 175-point decline. Read More The slump in shares of RIL and HDFC Bank collectively contributed around 140 points to the Nifty… Read More »Mid-day Mood: Indices under pressure as caution prevails before FOMC outcome
“The company has secured marketing authorisation from Serbia for gemcitablne and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer,” the company said in a regulatory filing. Read More “The company has secured marketing authorisation… Read More »Venus Remedies trades 2% up on approval to market cancer drugs in Serbia
Options data suggests call writers dominant for the day. At 11 AM, the Sensex was down 586.49 points or 0.87 percent at 67,010.35, and the Nifty was down 166.00 points or 0.82 percent at 19,967.30. About 1272 shares advanced, 1723… Read More »FO Manual | Nifty stays downhill with key resistance at 20,100 points
There’s reason to think that the misuse of Parliament to entrench otherness will soon be addressed. There’s hope because today, on its first day of functioning in the new building, Parliament has demonstrated that it isn’t opposed to rectifying inequities.… Read More »Opinion | Women’s reservation bill a great start, but India’s new Parliament must correct these 5 digressions
“Our company, which is a pioneer in the affordable housing segment in Gurugram, has now shifted focus to the mid-income housing segment as demand for branded developers in this segment has increased and there are barely any developers in this… Read More »Public issue to help strengthen Signature Global’s foothold in Gurugram market: Chairman
English 
हिन्दी